Clemson University will use an $11 million grant from the National Institutes of Health to grow a research program that hopes to find treatments for a variety of conditions that plague humankind, from heart disease to spinal cord injuries.
The money will be used to expand a bioengineering center where research will be conducted into laboratory-grown tissue that could one day become organs that could be used for transplants — a field known as regenerative medicine, officials said.
And much of the work will be done in Greenville at CUBEInc, the Clemson University Biomedical Engineering Campus, which is located at Greenville Health System’s Patewood Medical Campus.
“We’re on the right track,” Clemson University President James P. Clements said. “The NIH has invested more than $20 million in Clemson’s program since 2009. This level of funding is a great vote of confidence in our bioengineering faculty and their research.”